PROCEPT BioRobotics Stock Forecast
NASDAQ: PRCTHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PRCT analyst consensus
Consensus (15 analysts)
hold
Avg. price target
$22.42+25.18%
- Strong buy 2
- Buy 3
- Hold 9
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 15 Wall Street analysts covering PROCEPT BioRobotics (2026-10-08), 5 rate the stock a buy or strong buy, 9 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "hold". The average 12-month price target is $22.42, with a high estimate of $30.00 and a low estimate of $16.00. The average target implies upside of 25.2% from the current price of $17.91.
The spread between the highest and lowest targets is 87.5%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for PRCT.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 13% |
| Buy | 3 | 20% |
| Hold | 9 | 60% |
| Sell | 0 | 0% |
| Strong sell | 1 | 7% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $16.00 | -10.66% |
| Average target | $22.42 | +25.18% |
| High target | $30.00 | +67.50% |